Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
St. Jude Children's Research Hospital · NCT06421987
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- May 6, 2024
- Record last updated
- September 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
SURVIVORS
Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors.
Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. .
Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity.
CONTROLS
Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.
Being studied: Near Infrared Spectroscopy (NIRS)
Conditions: Hodgkin Lymphoma, Adult
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
HL Survivors
- Completed bleomycin and/or thoracic radiation therapy for HL at SJCRH.
- \<21-years old at diagnosis; currently ≥18-years of age and ≥2-years post therapy.
- SJLIFE or ACT/SJLIFE participants
- English language proficiency.
Community Controls
- SJLIFE control.
- ≥18-years of age at the time of enrollment with age sampling to broadly match the HL survivors.
Exclusion Criteria
HL Survivors
- History of cranial or total-body irradiation therapy.
- History of intrathecal or high dose intravenous antimetabolite therapy.
- History of head injury or diagnosis of a genetic disorder associated with cognitive impairment.
Recruiting US locations
St. Jude Children's Research Hospital
Memphis, TN 38105
Site contact: Nicholas Phillips, PhD · 888-226-4343 · referralinfo@stjude.org
Study contacts (from the official record)
- Nicholas Phillips, PhD · 888-226-4343 · referralinfo@stjude.org
Similar studies in Tennessee
All healthy volunteers studies in Tennessee →- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Cordova, TN + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Knoxville, TN + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Knoxville, TN + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.
Xfibra, Inc.
- Location
- Knoxville, TN
- Eligibility basics
- Ages 18–55